Pleiotrophin regulates microglia-mediated neuroinflammation

Abstract

BackgroundPleiotrophin (PTN) is a cytokine found highly upregulated in the brain in different disorders characterized by overt neuroinflammation such as neurodegenerative diseases, drug addiction, traumatic injury, and ischemia. In the present work, we have explored whether PTN modulates neuroinflammation and if Toll-like receptor 4 (TLR4), crucial in the initiation of an immune response, is involved.MethodsIn immunohistochemistry assays, we studied lipopolysaccharide (LPS, 7.5 mg/kg i.p.)-induced changes in glial fibrillary acidic protein (GFAP, astrocyte marker) and ionized calcium-binding adaptor molecule 1 (Iba1, microglia marker) expression in the prefrontal cortex (PFC) and striatum of mice with transgenic PTN overexpression in the brain (PTN-Tg) and in wild-type (WT) mice. Cytokine protein levels were assessed in the PFC by X-MAP technology. The influence of TLR4 signaling in LPS effects in both genotypes was assessed by pretreatment with the TLR4 antagonist (TAK-242, 3.0 mg/kg i.p.). Murine BV2 microglial cells were treated with PTN (0.5 μg/ml) and LPS (1.0 μg/ml) and assessed for the release of nitric oxide (NO).ResultsWe found that LPS-induced microglial activation is significantly increased in the PFC of PTN-Tg mice compared to that of WT mice. The levels of TNF-α, IL-6, and MCP-1 in response to LPS were significantly increased in the PFC of PTN-Tg mice compared to that of WT mice. Pretreatment with TAK-242 efficiently blocked increases in cytokine contents in a similar manner in both genotypes. Concomitant incubation of BV2 cells with LPS and PTN significantly potentiated the production of NO compared to cells only treated with LPS.ConclusionsOur findings identify for the first time that PTN is a novel and potent regulator of neuroinflammation. Pleiotrophin potentiates LPS-stimulated microglia activation. Our results suggest that regulation of the PTN signaling pathways may constitute new therapeutic opportunities particularly in those neurological disorders characterized by increased PTN cerebral levels and neuroinflammation.

IL-33/ST2 plays a critical role in endothelial cell activation and microglia-mediated neuroinflammation modulation

“…5 e–h). Iba-1 is considered as the activation marker of microglia [ 32 , 33 ]. Immunostaining with anti-Iba1 showed that LPS-treated IL-33 −/− mice had substantially lower numbers of activated microglial cells in cortex sections than LPS-injected WT mice (Fig.…”

Interactions of Notch1 and TLR4 signaling pathways in DRG neurons of in vivo and in vitro models of diabetic neuropathy

“…TAK-242 (TAK) is a novel antagonist of TLR4 and effectively decreases neuroinflammation by its efficacy on blocking TLR4 to bind with its downstream adaptor protein 1 , 20 . In many experimental conditions, inhibition of TLR4 by TAK induced decreases of TLR4 expression 1 , 20 , 21 . The effect of TAK on reducing neuroinflammation in diabetic neuropathy should be further explored.…”

The potential role of collagens in congenital Zika syndrome: A systems biology approach

“…Successful viral infection and disease must overcome the organism immune response. Pleiotrophin (PTN) is a cytokine that modulates inflammation in the CNS 46 . Additionally, PTN negatively regulates protein tyrosine phosphatase zeta (PTPRZ1), which binds to developmental proteins such as beta-catenin 47 .…”